Brazil · Seed startup

Who invested in Neurogram

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIHealthcareHealthtech

Funding summaryUpdated 15 Nov 2026

$3.0Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $3.0MJul 2025
Led by
Headline
Investors
2 (1 led)
See who backed them

The rounds

  1. Jul 2025
    Seed$3.0M

    Reported by LatamList

Founders and team

From Neurogram's own website: 4 on the team.

  • Daniele De MariCofounder & CEO
  • Anderson CarubelliChief Technology Officer
  • Cristhian CagliariChief Revenue Officer
  • Heitor EttoriCofounder & Chief Scientific Officer

Everyone who backed them

HeadlineVC firm1round, led 1
Hustle FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Neurogram as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Dorm Room FundVC firmPer its own site

Quick answers about Neurogram

Who invested in Neurogram?

Neurogram's investors include Headline and Hustle Fund. Headline led its latest round.

How much has Neurogram raised?

Neurogram has raised $3.0M across 1 round since 2025.

When did Neurogram last raise?

Neurogram's most recent round was a Seed of $3.0M in Jul 2025, led by Headline.

What was Neurogram's biggest round?

Its most recent round, $3.0M in Jul 2025, is also its largest on record.

Who backed Neurogram first?

Neurogram's first round on record, in Jul 2025, was backed by Headline and Hustle Fund.

What stage is Neurogram at?

Neurogram's latest named round is a Seed, in Jul 2025.

Where is Neurogram based?

Neurogram is based in Brazil.

Who led Neurogram's rounds?

Headline led the Seed in 2025.

Companies like Neurogram

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.